the primary aim of this multicentre , randomised , double-blind , crossover study in 529 patients with stable angina pectoris was to compare the tolerability of epanolol , a novel antianginal agent , administered as a single oral daily dose of 200mg , with an oral retard formulation of twice-daily nifedipine 20mg and to determine patient preference ( visa 2 ) .
C0340288
stable angina pectoris
C0028066
nifedipine